APO RESEARCH · REPORT
Artificial Pancreas Devices Systems
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Product & engineering
Understand the product.
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Selected research
Market Structure
Global Artificial Pancreas Devices Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
Read the full market overview
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report provides an overview of the global Artificial Pancreas Devices Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artificial Pancreas Devices Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artificial Pancreas Devices Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Pancreas Devices Systems market size, projected growth trends, production technologies, key applications, and end-use industries.
Artificial Pancreas Devices Systems Segment by Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Artificial Pancreas Devices Systems Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Artificial Pancreas Devices Systems Segment by Application
Hospitals
Clinics
Artificial Pancreas Devices Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artificial Pancreas Devices Systems market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Threshold Suspended Device Systems
- Hybrid Closed-loop APDS
- Other Systems
Applications
- Hospitals
- Clinics
Companies covered
- Medtronic
- Bigfoot Biomedical
- Beta Bionics
- Admetsys
- Insulet
- Tandem Diabetes Care
- Defymed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Artificial Pancreas Devices Systems Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Artificial Pancreas Devices Systems Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Artificial Pancreas Devices Systems Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Artificial Pancreas Devices Systems Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Artificial Pancreas Devices Systems Market Dynamics
- 2.1 Artificial Pancreas Devices Systems Industry Trends
- 2.2 Artificial Pancreas Devices Systems Industry Drivers
- 2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
- 2.4 Artificial Pancreas Devices Systems Industry Restraints
3 Artificial Pancreas Devices Systems Market by Manufacturers
- 3.1 Global Artificial Pancreas Devices Systems Revenue by Manufacturers (2021-2026)
- 3.2 Global Artificial Pancreas Devices Systems Sales by Manufacturers (2021-2026)
- 3.3 Global Artificial Pancreas Devices Systems Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Artificial Pancreas Devices Systems Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artificial Pancreas Devices Systems Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artificial Pancreas Devices Systems Manufacturers, Product Type & Application
- 3.7 Global Artificial Pancreas Devices Systems Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artificial Pancreas Devices Systems Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artificial Pancreas Devices Systems Players Market Share by Revenue in 2025
- 3.8.3 2025 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier 3
4 Artificial Pancreas Devices Systems Market by Type
- 4.1 Artificial Pancreas Devices Systems Type Introduction
- 4.1.1 Threshold Suspended Device Systems
- 4.1.2 Hybrid Closed-loop APDS
- 4.1.3 Other Systems
- 4.2 Global Artificial Pancreas Devices Systems Sales by Type
- 4.2.1 Global Artificial Pancreas Devices Systems Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artificial Pancreas Devices Systems Sales by Type (2021-2032)
- 4.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Type (2021-2032)
- 4.3 Global Artificial Pancreas Devices Systems Revenue by Type
- 4.3.1 Global Artificial Pancreas Devices Systems Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artificial Pancreas Devices Systems Revenue by Type (2021-2032)
- 4.3.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Type (2021-2032)
5 Artificial Pancreas Devices Systems Market by Application
- 5.1 Artificial Pancreas Devices Systems Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Artificial Pancreas Devices Systems Sales by Application
- 5.2.1 Global Artificial Pancreas Devices Systems Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artificial Pancreas Devices Systems Sales by Application (2021-2032)
- 5.2.3 Global Artificial Pancreas Devices Systems Sales Market Share by Application (2021-2032)
- 5.3 Global Artificial Pancreas Devices Systems Revenue by Application
- 5.3.1 Global Artificial Pancreas Devices Systems Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artificial Pancreas Devices Systems Revenue by Application (2021-2032)
- 5.3.3 Global Artificial Pancreas Devices Systems Revenue Market Share by Application (2021-2032)
6 Global Artificial Pancreas Devices Systems Sales by Region
- 6.1 Global Artificial Pancreas Devices Systems Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artificial Pancreas Devices Systems Sales by Region (2021-2032)
- 6.2.1 Global Artificial Pancreas Devices Systems Sales by Region (2021-2026)
- 6.2.2 Global Artificial Pancreas Devices Systems Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artificial Pancreas Devices Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artificial Pancreas Devices Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artificial Pancreas Devices Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Artificial Pancreas Devices Systems Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Artificial Pancreas Devices Systems Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Artificial Pancreas Devices Systems Revenue by Region
- 7.1 Global Artificial Pancreas Devices Systems Revenue by Region
- 7.1.1 Global Artificial Pancreas Devices Systems Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Artificial Pancreas Devices Systems Revenue by Region (2021-2026)
- 7.1.3 Global Artificial Pancreas Devices Systems Revenue by Region (2027-2032)
- 7.1.4 Global Artificial Pancreas Devices Systems Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Artificial Pancreas Devices Systems Revenue (2021-2032)
- 7.2.2 North America Artificial Pancreas Devices Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Artificial Pancreas Devices Systems Revenue (2021-2032)
- 7.3.2 Europe Artificial Pancreas Devices Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Artificial Pancreas Devices Systems Revenue (2021-2032)
- 7.4.2 Asia-Pacific Artificial Pancreas Devices Systems Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Artificial Pancreas Devices Systems Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Artificial Pancreas Devices Systems Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Medtronic
- 8.1.1 Medtronic Company Information
- 8.1.2 Medtronic Business Overview
- 8.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
- 8.1.5 Medtronic Recent Developments
- 8.2 Bigfoot Biomedical
- 8.2.1 Bigfoot Biomedical Company Information
- 8.2.2 Bigfoot Biomedical Business Overview
- 8.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
- 8.2.5 Bigfoot Biomedical Recent Developments
- 8.3 Beta Bionics
- 8.3.1 Beta Bionics Company Information
- 8.3.2 Beta Bionics Business Overview
- 8.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
- 8.3.5 Beta Bionics Recent Developments
- 8.4 Admetsys
- 8.4.1 Admetsys Company Information
- 8.4.2 Admetsys Business Overview
- 8.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
- 8.4.5 Admetsys Recent Developments
- 8.5 Insulet
- 8.5.1 Insulet Company Information
- 8.5.2 Insulet Business Overview
- 8.5.3 Insulet Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
- 8.5.5 Insulet Recent Developments
- 8.6 Tandem Diabetes Care
- 8.6.1 Tandem Diabetes Care Company Information
- 8.6.2 Tandem Diabetes Care Business Overview
- 8.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
- 8.6.5 Tandem Diabetes Care Recent Developments
- 8.7 Defymed
- 8.7.1 Defymed Company Information
- 8.7.2 Defymed Business Overview
- 8.7.3 Defymed Artificial Pancreas Devices Systems Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
- 8.7.5 Defymed Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Artificial Pancreas Devices Systems Value Chain Analysis
- 9.1.1 Artificial Pancreas Devices Systems Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artificial Pancreas Devices Systems Production Mode & Process
- 9.2 Artificial Pancreas Devices Systems Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artificial Pancreas Devices Systems Distributors
- 9.2.3 Artificial Pancreas Devices Systems Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst